Efficacy versus Effectiveness: A Direct Comparison of the Outcome of Treatment for Mild to Moderate Depression in Randomized Controlled Trials and Daily Practice

被引:50
作者
van der Lem, Rosalind [1 ]
van der Wee, Nic J. A. [1 ,2 ]
van Veen, Tineke [1 ]
Zitman, Frans G. [1 ]
机构
[1] Leiden Univ, Med Ctr Rivierduinen, Dept Psychiat, NL-2300 RC Leiden, Netherlands
[2] Leiden Inst Brain & Cognit, Leiden, Netherlands
关键词
Major depressive disorder; Efficacy; Effectiveness; Randomized controlled trials; Meta-analyses; Treatment outcome; Routine clinical practice; Routine outcome monitoring; SEROTONIN REUPTAKE INHIBITORS; STAR-ASTERISK-D; MAJOR DEPRESSION; TRICYCLIC ANTIDEPRESSANTS; CLINICAL-PRACTICE; MONTGOMERY-ASBERG; REMISSION RATES; DEFINING REMISSION; METAANALYSIS; PSYCHOTHERAPY;
D O I
10.1159/000330890
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background: Results from randomized controlled trials (RCTs) are considered to give the most reliable information on treatment outcome (efficacy). Yet, the generalizability of efficacy results to daily practice (effectiveness) might be diminished by the design of RCTs. The STAR*D trial approached daily practice as much as possible, but still has some properties of an RCT. In this study, we compare results from treatment of major depressive disorder (MDD) in routine clinical practice to those of RCTs and STAR*D. Methods: Effectiveness in routine clinical practice was compared with efficacy results from 15 meta-analyses on antidepressant, psychotherapeutic and combination treatment and results from STAR*D. Data on daily practice patients and treatments were derived from a routine outcome monitoring (ROM) system. Treatment outcome was defined as proportion of remitters (MADRS <= 10) and within-group effect size. Results: From ROM, 598 patients suffering from a MDD episode according to the MINI-plus were included. Remission percentages were lower in routine practice than in meta-analyses for all treatment modalities (32 vs.40-74%). Differences were less explicit for antidepressants (21 vs. 34-47%) than for individual psychotherapy (27 vs. 34-58%; effect size 0.85 vs. 1.71) and combination therapy (21 vs. 45-63%), since only 60% of the meta-analyses for antidepressants showed significant differences with ROM, while for psychotherapy and combination treatment almost all meta-analyses showed significant differences. No differences in effectiveness were found between routine practice and STAR*D (antidepressants 27 vs. 28%; individual psychotherapy 27 vs. 25%; combination treatment 21 vs. 23%, respectively). Conclusions: Effectiveness of treatment for mild-to-moderate MDD in daily practice is similar to STAR*D and significantly lower than efficacy results from RCTs. Copyright (C) 2012 S. Karger AG, Basel
引用
收藏
页码:226 / 234
页数:9
相关论文
共 56 条
  • [1] Altman D G., 1991, Practical statistics for medical research, V1st, P179
  • [2] Altman DG., 1991, Practical statistics for medical research, P229, DOI [DOI 10.1201/9780429258589, https://doi.org/10.1201/9780429258589]
  • [3] ASBERG M, 1978, ACTA PSYCHIAT SCAND, P5
  • [4] What is the threshold for symptomatic response and remission for major depressive disorder, panic disorder, social anxiety disorder, and generalized anxiety disorder?
    Bandelow, Borwin
    Baldwin, David S.
    Dolberg, Ornah T.
    Andersen, Henning Friis
    Stein, Dan J.
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2006, 67 (09) : 1428 - 1434
  • [5] Effects of psychological therapies in randomized trials and practice-based studies
    Barkham, Michael
    Stiles, William B.
    Connell, Janice
    Twigg, Elspeth
    Leach, Chris
    Lucock, Mike
    Mellor-Clark, John
    Bower, Peter
    King, Michael
    Shapiro, David A.
    Hardy, Gillian E.
    Greenberg, Leslie
    Angus, Lynne
    [J]. BRITISH JOURNAL OF CLINICAL PSYCHOLOGY, 2008, 47 : 397 - 415
  • [6] Efficacy, adverse events, and treatment discontinuations in fluoxetine clinical studies of major depression: A meta-analysis of the 20-mg/day dose
    Beasley, CM
    Nilsson, ME
    Koke, SC
    Gonzales, JS
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2000, 61 (10) : 722 - 728
  • [7] Struggle for Subtypes in Primary and Secondary Depression and Their Mode-Specific Treatment or Healing
    Bech, P.
    [J]. PSYCHOTHERAPY AND PSYCHOSOMATICS, 2010, 79 (06) : 331 - 338
  • [8] Meta-analysis of randomised controlled trials of fluoxetine v. placebo and tricyclic antidepressants in the short-term treatment of major depression
    Bech, P
    Cialdella, P
    Haugh, MC
    Birkett, MA
    Hours, A
    Boissel, JP
    Tollefson, GD
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 2000, 176 : 421 - 428
  • [9] AN INVENTORY FOR MEASURING DEPRESSION
    BECK, AT
    ERBAUGH, J
    WARD, CH
    MOCK, J
    MENDELSOHN, M
    [J]. ARCHIVES OF GENERAL PSYCHIATRY, 1961, 4 (06) : 561 - &
  • [10] SYNTHESIZING STANDARDIZED MEAN-CHANGE MEASURES
    BECKER, BJ
    [J]. BRITISH JOURNAL OF MATHEMATICAL & STATISTICAL PSYCHOLOGY, 1988, 41 : 257 - 278